MedTrace Logo

Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

NCT03807947 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2019-01-17

No results posted yet for this study

Summary

The aim of this prospective, randomized study is to compare TRA vs TFA for superselective embolization of HCC using bland microparticles performed by multiple operators.

In particular, main objectives are to compare:

1. the success rates of TRA and TFA including crossing over events between techniques
2. the inter-operator outcomes in terms of time to complete the vascular access and the vessel catheterization
3. access-related adverse events
4. patient preference and reported discomfort

Conditions

Interventions

PROCEDURE

Radial TAE - Bland embolization with 40-100 Microparticles

TAE - Bland embolization with 40-100 Microparticles performed via left transradial access

PROCEDURE

Transfemoral TAE - Bland embolization with 40-100 Microparticles

TAE - Bland embolization with 40-100 Microparticles performed via right transfemoral access

Sponsors & Collaborators

  • Humanitas Clinical and Research Center

    lead OTHER

Principal Investigators

  • EZIO LANZA, MD · Humanitas Research Hospital IRCCS, Rozzano-Milan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2019-12-31
Completion
2020-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807947 on ClinicalTrials.gov